TScan Therapeutics, Inc. (TCRX) Retained Earnings (Accumulated Deficit) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
TScan Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2020 to 2024.
  • TScan Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$278 M, a 53.5% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$278 M -$96.8 M -53.5% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$248 M -$89.2 M -56.3% Dec 31, 2023 10-Q 2024-05-13
Q3 2023 -$228 M -$88.3 M -63.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$205 M -$81.6 M -66.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$181 M -$72.6 M -67.1% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 -$158 M -$66.2 M -71.9% Dec 31, 2022 10-K 2024-03-06
Q3 2022 -$140 M -$61.7 M -79.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$123 M -$61.3 M -98.7% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 -$108 M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$92.2 M -$48.6 M -112% Dec 31, 2021 10-K 2023-03-08
Q3 2021 -$78 M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$62.1 M Jun 30, 2021 10-Q 2021-08-19
Q4 2020 -$43.5 M Dec 31, 2020 10-K 2022-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.